High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects-Reference-Cited by-同舟云学术

High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects

Published:2018-12 Issue: Volume:38 Page:47-56
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Li Xia,Li Chenying,Jin Jingrui,Wang Jinghan,Huang Jiansong,Ma Zhixin,Huang Xin,He Xiao,Zhou Yile,Xu Yu,Yu Mengxia,Huang Shujuan,Yan Xiao,Li Fenglin,Pan Jiajia,Wang Yungui,Yu Yongping,Jin Jie^ORCID

Funder

National Natural Science Foundation of China

Zhejiang Provincial Key Innovation Team

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference60 articles.

1. DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours;Bartkova;Oncogene,2007

2. Role of poly(ADP-ribose) formation in DNA repair;Satoh;Nature,1992

3. PARP1 promoter links cell cycle progression with adaptation to oxidative environment;Pietrzak;Redox Biol,2018

4. PARP expression in germ cell tumours;Mego;J Clin Pathol,2013

5. Alternative NHEJ pathway components are therapeutic targets in high-risk neuroblastoma;Newman;Molecular Cancer Research : MCR,2015

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic targeting of PARP with immunotherapy in acute myeloid leukemia;Frontiers in Pharmacology;2024-08-08

2. Genetic and Epigenetic Biomarkers Associated with Early Relapse in Pediatric Acute Lymphoblastic Leukemia: A Focused Bioinformatics Study on DNA-Repair Genes;Biomedicines;2024-08-05

3. Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions;British Journal of Cancer;2024-03-09

4. High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response;Journal of Molecular Medicine;2024-02-10

5. Targeting the DNA damage response in hematological malignancies;Frontiers in Oncology;2024-01-29